2 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
Follow Embolism: new trials by email Literature Review of Embolism trials Research Report on Embolism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of iNO in Patients With Submassive and Massive PE inhaled nitric oxide (iNO) - Pulmonary Embolism, Pulmonary Embolism Subacute Massive | Phase 2 | Withdrawn | University of California, Los Angeles | 2026-06-01 | 2026-03-18 | |
| DS-9231 in Intermediate-risk (Sub-massive) Acute Pulmonary Embolism (PE) DS-9231, Placebo - Pulmonary Embolism | Phase 2 | Withdrawn | Daiichi Sankyo | 2018-01-01 | 2018-12-24 |
Cardiovascular Diseases (2) · Embolism and Thrombosis (2) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Vascular Diseases (2)
Endothelium-Dependent Relaxing Factors (1)
Daiichi Sankyo (1) · University of California, Los Angeles (1)
United States (1)
PMID 16598645, PMID 22005573, PMID 30633959, PMID 9407246
2017 (1)